[Management of chronic hepatitis B].
Chronic hepatitis B predisposes to the development of cirrhosis and hepatocellular carcinoma. Treatment of chronic hepatitis B is aimed at halting viral replication and, thereby, hepatic inflammation. Treatment indication should be established carefully and with full knowledge of the advantages and limitations of currently available antiviral drugs. Patients on long-term nudcleos(t)ide analogue treatment should be followed regularly in order to avoid the appearance of antiviral resistance. The purpose of this review is to provide a concise overview of the diagnosis and management of chronic hepatitis B.
Doerig
C
C
Service de gastro-entérologie et d'hépatologie, CHUV, 1011 Lausanne. Christopher.Doerig@chuv.ch
Antonino
A
A
Pache
I
I
Moradpour
D
D
D000998:Antiviral Agents / Q000627:therapeutic use*; D024882:Drug Resistance, Viral; D005838:Genotype; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000235:genetics / Q000821:virology; D006801:Humans
D000998:Antiviral Agents